(R,E)-N-(2-((tert-Butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide

Catalog No. :
ACFTXR906
CAS No. :
393536-19-1
Molecular Formula :
C12H27NO2SSi
Molecular Weight :
277.51

IUPAC Name:(R,E)-N-(2-((tert-butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide

(R,E)-N-(2-((tert-Butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$151.00Login to see priceInquiryInquiry
250mg95%$270.00Login to see priceInquiryInquiry
1g95%$720.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R,E)-N-(2-((tert-Butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide
IUPAC Name(R,E)-N-(2-((tert-butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide
Molecular FormulaC12H27NO2SSi
Molecular Weight277.51
SMILESCC([S@](/N=C/CO[Si](C)(C(C)(C)C)C)=O)(C)C
InChI KeyGYWHPULLAAZCJG-LRFDDAOPSA-N
Synonym2-Propanesulfinamide, N-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethylidene]-2-methyl-, [N(E),S(R)]-;(R,E)-N-(2-((tert-butyldimethylsilyl)oxy)ethylidene)-2-methylpropane-2-sulfinamide
CAS No.393536-19-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFTXR906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTXR906 route product structure diagram
    ACFTXR906393536-19-1
Inquiry

2. ACFTXR906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFUY803 route compound structure diagram
    ACNFUY803102191-92-4 In Stock
  2. Then
  3. ACFTXR906 route product structure diagram
    ACFTXR906393536-19-1
Inquiry

Comments (0)